Squamous cell carcinoma of oropharynx TNM clinical staging | Squamous cell carcinoma of the hypopharynx TNM clinical staging | Laryngeal Squamous Cell Carcinoma TNM clinical staging
Item
1. t1/2n0-2m0 scc of the oropharynx, hypopharynx or larynx
boolean
C0280313 (UMLS CUI [1,1])
C3258246 (UMLS CUI [1,2])
C0280321 (UMLS CUI [2,1])
C3258246 (UMLS CUI [2,2])
C0280324 (UMLS CUI [3,1])
C3258246 (UMLS CUI [3,2])
Age
Item
2. age ≥ 18 years.
boolean
C0001779 (UMLS CUI [1])
ECOG performance status
Item
3. performance status ecog 0-1
boolean
C1520224 (UMLS CUI [1])
Organ function | Bone Marrow function
Item
4. adequate organ and marrow function as determined by medical oncology evaluation.
boolean
C0678852 (UMLS CUI [1])
C0005953 (UMLS CUI [2,1])
C0031843 (UMLS CUI [2,2])
Childbearing Potential Contraceptive methods | Gender Contraceptive methods | Hormonal contraception | Contraception, Barrier | Sexual Abstinence
Item
5. women of child-bearing potential and men must agree to use adequate contraception (hormonal or barrier method of birth control; abstinence) prior to study entry, for the duration of study participation, and for 90 days following completion of therapy. should a woman become pregnant or suspect she is pregnant while participating in this study, she should inform her treating physician immediately.
boolean
C3831118 (UMLS CUI [1,1])
C0700589 (UMLS CUI [1,2])
C0079399 (UMLS CUI [2,1])
C0700589 (UMLS CUI [2,2])
C2985296 (UMLS CUI [3])
C0004764 (UMLS CUI [4])
C0036899 (UMLS CUI [5])
Childbearing Potential Criteria Fulfill | Independent of Sexual Orientation | Tubal Ligation | Sexual Abstinence
Item
6. a female of child-bearing potential is any woman (regardless of sexual orientation, having undergone a tubal ligation, or remaining celibate by choice) who meets the following criteria:
boolean
C3831118 (UMLS CUI [1,1])
C0243161 (UMLS CUI [1,2])
C1550543 (UMLS CUI [1,3])
C0332291 (UMLS CUI [2,1])
C0205949 (UMLS CUI [2,2])
C0520483 (UMLS CUI [3])
C0036899 (UMLS CUI [4])
Hysterectomy Absent | Bilateral oophorectomy Absent
Item
has not undergone a hysterectomy or bilateral oophorectomy; or
boolean
C0020699 (UMLS CUI [1,1])
C0332197 (UMLS CUI [1,2])
C0278321 (UMLS CUI [2,1])
C0332197 (UMLS CUI [2,2])
Postmenopausal state Absent
Item
has not been naturally postmenopausal for at least 12 consecutive months (i.e., has had menses at any time in the preceding 12 consecutive months).
boolean
C0232970 (UMLS CUI [1,1])
C0332197 (UMLS CUI [1,2])
Informed Consent
Item
7 ability to understand and the willingness to sign a written informed consent.
boolean
C0021430 (UMLS CUI [1])
Creatinine clearance measurement | 24 hour renal creatinine clearance | Estimation of creatinine clearance by Cockcroft-Gault formula
Item
8. creatinine clearance (cc) ≥ 50 ml/min within 4 weeks prior to registration determined by 24-hour collection or estimated by cockcroft-gault formula: ccr male = [(140 - age) x (wt in kg)]/[(serum cr mg/dl) x (72)] (ccr female = 0.85 x (crcl male)).
boolean
C0373595 (UMLS CUI [1])
C4032392 (UMLS CUI [2])
C2711451 (UMLS CUI [3])
Medical History | Physical Examination | Assessment Body Weight | Assessment Weight loss
Item
9. history/physical examination within 4 weeks prior to registration, including assessment of weight and weight loss in past 6 months.
boolean
C0262926 (UMLS CUI [1])
C0031809 (UMLS CUI [2])
C1516048 (UMLS CUI [3,1])
C0005910 (UMLS CUI [3,2])
C1516048 (UMLS CUI [4,1])
C1262477 (UMLS CUI [4,2])
Medical oncology Examination | Evaluation Medical contraindication | DENTAL EVALUATION | Nutrition Evaluation | Consideration Percutaneous placement of gastrostomy tube | Distant metastasis Absent PET/CT scan
Item
10. medical oncology examination to evaluate medical contraindications prior to start chemotherapy 11 dental evaluation with management prior to start of radiation 12 nutrition evaluation with consideration of percutaneous endoscopic gastrostomy (peg) tube placement 13 no distant metastasis by pet/ct
boolean
C0025098 (UMLS CUI [1,1])
C0582103 (UMLS CUI [1,2])
C1261322 (UMLS CUI [2,1])
C1301624 (UMLS CUI [2,2])
C0011356 (UMLS CUI [3])
C3825905 (UMLS CUI [4])
C0518609 (UMLS CUI [5,1])
C0192460 (UMLS CUI [5,2])
C1269798 (UMLS CUI [6,1])
C0332197 (UMLS CUI [6,2])
C1699633 (UMLS CUI [6,3])
Disease TNM clinical staging
Item
1. t3/4 or n3
boolean
C0012634 (UMLS CUI [1,1])
C3258246 (UMLS CUI [1,2])
Disease TNM clinical staging
Item
2. t1n0 disease
boolean
C0012634 (UMLS CUI [1,1])
C3258246 (UMLS CUI [1,2])
Neoplasm Metastasis
Item
3. metastatic disease
boolean
C0027627 (UMLS CUI [1])
Invasive cancer | Exception Skin carcinoma | Exception Disease Free Duration
Item
4. prior invasive malignancy (except non-melanomatous skin cancer) unless disease free for a minimum of 3 years
boolean
C0677898 (UMLS CUI [1])
C1705847 (UMLS CUI [2,1])
C0699893 (UMLS CUI [2,2])
C1705847 (UMLS CUI [3,1])
C0012634 (UMLS CUI [3,2])
C0332296 (UMLS CUI [3,3])
C0449238 (UMLS CUI [3,4])
Prior radiation therapy Region Clinical Trial Malignant Neoplasm | With result Overlap Radiation Field
Item
5. prior radiotherapy to the region of the study cancer that would result in overlap of radiation therapy fields
boolean
C0279134 (UMLS CUI [1,1])
C0205147 (UMLS CUI [1,2])
C0008976 (UMLS CUI [1,3])
C0006826 (UMLS CUI [1,4])
C0332294 (UMLS CUI [2,1])
C1948020 (UMLS CUI [2,2])
C1882536 (UMLS CUI [2,3])
Primary tumor site Oral cavity | Primary tumor site Nasopharynx | Primary tumor site Sinuses | Primary tumor site Salivary Glands
Item
6. primary site of tumor of oral cavity, nasopharynx, sinuses, or salivary glands
boolean
C0475447 (UMLS CUI [1,1])
C0226896 (UMLS CUI [1,2])
C0475447 (UMLS CUI [2,1])
C0027442 (UMLS CUI [2,2])
C0475447 (UMLS CUI [3,1])
C0030471 (UMLS CUI [3,2])
C0475447 (UMLS CUI [4,1])
C0036098 (UMLS CUI [4,2])
Neck Adenopathy Involving Skin
Item
7. neck adenopathy that involves the overlying skin.
boolean
C0027530 (UMLS CUI [1,1])
C0497156 (UMLS CUI [1,2])
C1314939 (UMLS CUI [1,3])
C1123023 (UMLS CUI [1,4])
Operative Surgical Procedure Initial | Tonsillectomy | Neck Dissection | Exception Biopsy Primary tumor site | Exception Sampling of lymph node Disorder of neck
Item
8. initial surgical treatment including tonsillectomy or neck dissection, but excluding diagnostic biopsy of the primary site or nodal sampling of neck disease
boolean
C0543467 (UMLS CUI [1,1])
C0205265 (UMLS CUI [1,2])
C0040423 (UMLS CUI [2])
C0398395 (UMLS CUI [3])
C1705847 (UMLS CUI [4,1])
C0005558 (UMLS CUI [4,2])
C0475447 (UMLS CUI [4,3])
C1705847 (UMLS CUI [5,1])
C0398417 (UMLS CUI [5,2])
C0558385 (UMLS CUI [5,3])
Sensory neuropathy Pre-existing CTCAE Grades
Item
9. pre-existing grade > 2 peripheral sensory neuropathy
boolean
C0151313 (UMLS CUI [1,1])
C2347662 (UMLS CUI [1,2])
C1516728 (UMLS CUI [1,3])
Investigational New Drugs
Item
10. subjects may not be receiving any other investigational agents.
boolean
C0013230 (UMLS CUI [1])
Comorbidity Uncontrolled | Communicable Disease | Symptomatic congestive heart failure | Angina, Unstable | Cardiac Arrhythmia | Mental disorders Limiting Protocol Compliance | Social situation Limiting Protocol Compliance
Item
11. uncontrolled intercurrent illness including, but not limited to, ongoing or active infection, symptomatic congestive heart failure, unstable angina pectoris, cardiac arrhythmia, or psychiatric illness/social situations that would limit compliance with study requirements.
boolean
C0009488 (UMLS CUI [1,1])
C0205318 (UMLS CUI [1,2])
C0009450 (UMLS CUI [2])
C0742758 (UMLS CUI [3])
C0002965 (UMLS CUI [4])
C0003811 (UMLS CUI [5])
C0004936 (UMLS CUI [6,1])
C0439801 (UMLS CUI [6,2])
C0525058 (UMLS CUI [6,3])
C0748872 (UMLS CUI [7,1])
C0439801 (UMLS CUI [7,2])
C0525058 (UMLS CUI [7,3])
Pregnancy | Breast Feeding
Item
12. subjects must not be pregnant or nursing due to the potential for congenital abnormalities and the potential of this regimen to harm nursing infants.
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])